Skip to main content

Table 2 Clinical presentations

From: Early and mid-term outcomes after aortic valve intervention in patients with previous stentless or stented bioprostheses

Variable

N—Stented

Stat—Stented

N—Stentless

Stat—Stentless

P value

Most severe angina pectoris within one month prior to surgery

100

 

12

 

0.30

 Acute coronary insufficiency: prolonged episodes of unprovoked pain (> 15 min) despite medical therapy

 

1 (1%)

 

1 (8%)

 

 Crescendo: increasing frequency or severity of symptoms

 

2 (2%)

 

0 (0%)

 

 None

 

83 (83%)

 

9 (75%)

 

 Stable: predictable exertional angina

 

14 (14%)

 

2 (17%)

 

Infective endocarditis

99

 

11

 

0.51

 Active

 

5 (5%)

 

0 (0%)

 

 Active abscess

 

9 (9%)

 

0 (0%)

 

 Remote

 

13 (13%)

 

0 (0%)

 

Most recent myocardial infarction within 30 days of OR date

99

 

8

 

0.090

 Non-Q wave infarction

 

3 (3%)

 

0 (0%)

 

 Transmural infarction

 

0 (0%)

 

1 (12%)

 

NYHA classification (cardiac disability)

100

 

12

 

0.190

 No restrictions

 

11 (11%)

 

4 (33%)

 

 Symptoms provoked by exertion beyond daily activity

 

10 (10%)

 

0 (0%)

 

 Symptoms provoked by normal daily activity

 

41 (41%)

 

4 (33%)

 

 Unprovoked symptoms

 

38 (38%)

 

4 (33%)

 

LV grade based on LV ejection fraction

100

 

12

 

0.84

 < 20%

 

1 (1%)

 

0 (0%)

 

 >  = 60%

 

46 (46%)

 

7 (58%)

 

 20–39

 

11 (11%)

 

1 (8%)

 

 40–59

 

42 (42%)

 

4 (33%)